Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intramuscular

Polymyxin B

Polymyxin B Sulfate

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCA07AA05
RxCUI (US)8536
US makers1 labelers
Packages1
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a132639522025 Q12025 Q22025 Q32025 Q42026 Q1
16
Rx · 2026 Q1
25
Units dispensed
4
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Eugia US LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 26, 2022
    RECALLRecall (Class I): Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, …

    Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot — Recalling firm: AuroMedics Pharma LLC — Nationwide in the US